Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 11:31 PM
NCT ID:
NCT05287893
Population Description:
10 participants received inoculum and were included in the Full Analysis Set. 9 inoculated participants received 360mg (n=4), 560mg (n=4), or 720mg (n=1) pyronaridine, and included in the IMP Set, PK Analysis Set, PD Analysis Set, and the PK/PD Analysis Set. Some of the 18S qPCR data for the inoculated participant who was not administered pyronaridine was used in the PD model for PK/PD analyses.
Analysis and results were grouped per dose/arm, not per cohort.
Study:
NCT05287893
Study Brief:
Results Section:
NCT05287893